You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy

  • Technology appraisal guidance
  • Reference number: TA323
  • Published:  26 November 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541]: final appraisal determination document

Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541]: final appraisal determination document Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541]: final appraisal determination document
24 October 2014
(208.82 Kb 1 mins )

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 22 October 2014

Back to top